#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	3004	16S	1529	1529	99.93	16S.l15.c17.ctg.1	2789	252.3	0	.	n	.	0	C451T	SNP	451	451	C	1058	1058	T	360	T,C,A	248,93,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	3004	16S	1529	1529	99.93	16S.l15.c17.ctg.1	2789	252.3	1	SNP	n	C1184T	0	.	.	1184	1184	C	1791	1791	C	272	C	267	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	3004	16S	1529	1529	99.93	16S.l15.c17.ctg.1	2789	252.3	0	HET	.	.	.	C207T,G,A	.	207	207	C	814	814	C	267	C,T,G,A	193,53,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	4978	23S	2890	2890	99.93	23S.l6.c17.ctg.1	4068	293.0	0	.	n	.	0	T695C	SNP	695	695	T	1280	1280	C	275	C	265	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	4978	23S	2890	2890	99.93	23S.l6.c17.ctg.1	4068	293.0	0	.	n	.	0	T1971C	SNP	1971	1971	T	2556	2556	C	344	C,G	327,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	4978	23S	2890	2890	99.93	23S.l6.c17.ctg.1	4068	293.0	1	SNP	n	A2045G	0	.	.	2045	2045	A	2630	2630	A	332	A	322	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	4978	23S	2890	2890	99.93	23S.l6.c17.ctg.1	4068	293.0	1	SNP	n	C2597T	0	.	.	2597	2597	C	3182	3182	C	343	C	325	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	4978	23S	2890	2890	99.93	23S.l6.c17.ctg.1	4068	293.0	0	HET	.	.	.	A1638G,C,T	.	1638	1638	A	2223	2223	A	318	A,G,C,T	231,74,2,1	.	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	578	folP	855	855	100.0	folP.l15.c4.ctg.1	2221	60.7	1	SNP	p	R229S	1	.	.	685	687	AGC	1478	1480	AGC	72;73;71	A;G;C	69;71;68	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	155	1246	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3730	78.8	1	SNP	p	S91F	1	.	.	271	273	TTC	703	705	TTC	61;61;61	T;T;C	57;56;58	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	155	1246	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3730	78.8	1	SNP	p	D95G	1	.	.	283	285	GGC	715	717	GGC	63;65;65	G;G;C	61;63;59	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	155	1246	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3730	78.8	1	SNP	p	G95N	0	.	.	283	285	GGC	715	717	GGC	63;65;65	G;G;C	61;63;59	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	155	1246	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3730	78.8	0	HET	.	.	.	G2321C,T	.	2321	2321	G	2753	2753	G	61	G,C,T	39,5,1	.	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	155	1246	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3730	78.8	0	HET	.	.	.	C2320G,T,A	.	2320	2320	C	2752	2752	C	60	C,G,T,A	40,8,1,1	.	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	155	1246	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3730	78.8	0	HET	.	.	.	G2312C	.	2312	2312	G	2744	2744	G	60	G,C	31,5	.	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	27	454	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	2068	53.8	1	SNP	p	G45D	0	.	.	133	135	GGC	866	868	GGC	109;111;111	G;G;C	102;100;102	mtrR.WHO_O_01438:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	340	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1747	47.5	0	.	n	.	0	A197.	DEL	197	197	A	958	958	A	109	A,T	106,1	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1432	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3796	91.4	1	SNP	p	D86N	0	.	.	256	258	GAC	1199	1201	GAC	88;89;90	G;A;C	71;57;71	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1432	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3796	91.4	1	SNP	p	R87W	0	.	.	259	261	CGT	1202	1204	CGT	90;91;92	C;G;T	82;69;77	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1432	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3796	91.4	1	SNP	p	R87I	0	.	.	259	261	CGT	1202	1204	CGT	90;91;92	C;G;T	82;69;77	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1432	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3796	91.4	1	SNP	p	S87R	1	.	.	259	261	CGT	1202	1204	CGT	90;91;92	C;G;T	82;69;77	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1432	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3796	91.4	1	SNP	p	S88P	0	.	.	262	264	TCC	1205	1207	TCC	92;92;92	T;C,T;C	80;80,1;82	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	1250	parE	1986	1986	100.0	parE.l15.c17.ctg.1	3459	88.3	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1957	1959	GGC	101;102;102	G;G;C	90;86;81	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.002	penA.34.002	1	1	27	878	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2856	72.5	1	SNP	p	A311V	0	.	.	931	933	GCC	1655	1657	GCC	102;102;102	G;C,G;C	98;98,1;99	penA.34.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.002	penA.34.002	1	1	27	878	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2856	72.5	1	SNP	p	I312M	1	.	.	934	936	ATG	1658	1660	ATG	102;102;102	A;T,A;G	99;98,1;98	penA.34.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.002	penA.34.002	1	1	27	878	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2856	72.5	1	SNP	p	V316T	1	.	.	946	948	ACC	1670	1672	ACC	106;106;106	A;C;C	103;103;103	penA.34.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.002	penA.34.002	1	1	27	878	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2856	72.5	1	SNP	p	T316P	0	.	.	946	948	ACC	1670	1672	ACC	106;106;106	A;C;C	103;103;103	penA.34.002:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.002	penA.34.002	1	1	27	878	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2856	72.5	1	SNP	p	T483S	0	.	.	1447	1449	ACC	2171	2173	ACC	91;90;89	A,C;C;C,A	80,1;80;83,1	penA.34.002:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.002	penA.34.002	1	1	27	878	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2856	72.5	1	SNP	p	A501V	0	.	.	1501	1503	GCG	2225	2227	GCG	80;79;79	G;C;G	69;63;69	penA.34.002:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.002	penA.34.002	1	1	27	878	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2856	72.5	1	SNP	p	A501P	0	.	.	1501	1503	GCG	2225	2227	GCG	80;79;79	G;C;G	69;63;69	penA.34.002:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.002	penA.34.002	1	1	27	878	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2856	72.5	1	SNP	p	G542S	0	.	.	1624	1626	GGT	2348	2350	GGT	77;77;78	G,T;G,T;T	73,1;70,4;75	penA.34.002:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.002	penA.34.002	1	1	27	878	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2856	72.5	1	SNP	p	G545S	1	.	.	1633	1635	AGC	2357	2359	AGC	74;75;75	A,G;G,A;C,G,A	43,2;59,1;50,2,1	penA.34.002:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.002	penA.34.002	1	1	27	878	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2856	72.5	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2375	2377	CCG	69;67;68	C,G;C;G,C,T	57,1;54;53,2,1	penA.34.002:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	783	1270	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3994	76.2	1	SNP	p	L421P	1	.	.	1261	1263	CCG	2056	2058	CCG	117;117;118	C,G,T;C,G,A;G,C,A	89,9,1;108,2,1;80,7,1	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	783	1270	ponA	2397	573	99.68	ponA.l15.c4.ctg.2	620	0.0	0	.	p	.	0	G22fs	FSHIFT	64	64	G	500	500	C	ND	ND	ND	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	540	porA	1146	1146	99.91	porA.l15.c4.ctg.1	2506	52.4	0	.	p	.	0	M83fs	FSHIFT	247	247	A	912	912	C	43	C	35	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	704	porB1b	1038	1038	99.81	porB1b.l15.c4.ctg.1	2539	67.1	0	.	p	.	0	G210R	NONSYN	628	630	GGA	1355	1357	AGA	91;92;92	A,C;G;A	89,1;90;91	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	704	porB1b	1038	1038	99.81	porB1b.l15.c4.ctg.1	2539	67.1	0	.	p	.	0	S217G	NONSYN	649	651	AGT	1376	1378	GGT	88;88;90	G;G,T;T	86;82,1;83	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	704	porB1b	1038	1038	99.81	porB1b.l15.c4.ctg.1	2539	67.1	1	SNP	p	G120K	1	.	.	358	360	AAG	1085	1087	AAG	83;83;83	A;A;G	81;81;81	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	704	porB1b	1038	1038	99.81	porB1b.l15.c4.ctg.1	2539	67.1	1	SNP	p	N121D	0	.	.	361	363	AAC	1088	1090	AAC	84;84;84	A;A;C,A	81;81;79,1	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	704	porB1b	1038	1038	99.81	porB1b.l15.c4.ctg.1	2539	67.1	1	SNP	p	A121N	1	.	.	361	363	AAC	1088	1090	AAC	84;84;84	A;A;C,A	81;81;79,1	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	2142	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5629	92.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	292	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1782	40.4	1	SNP	p	V57M	1	.	.	169	171	ATG	898	900	ATG	73;73;75	A;T;G,A	68;71;72,1	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
